Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gyorki DE"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-14 z 14
    Tytuł:
    Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study.
    Autorzy:
    Smith, Andrea L
    Watts, Caroline G
    Robinson, Samuel
    Schmid, Helen
    Goumas, Chris
    Mar, Victoria J
    Thompson, John F
    Rapport, Frances
    Cust, Anne E
    Braithwaite, J
    Gyorki, DE
    Henderson, M
    Hong, AM
    Kelly, JW
    Long, GV
    Menzies, AM
    Morton, RL
    Saw, RPM
    Scolyer, RA
    Spillane, AJ
    Pokaż więcej
    Temat:
    SENTINEL lymph node biopsy
    MELANOMA
    CANCER patients
    DERMATOLOGISTS
    ATTITUDE (Psychology)
    Źródło:
    Australasian Journal of Dermatology; May2021, Vol. 62 Issue 2, p168-176, 9p, 2 Diagrams, 4 Charts
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma.
    Autorzy:
    Apte SS; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Division of General Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
    Mor E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
    Mitchell C; Division of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
    Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
    Pokaż więcej
    Źródło:
    Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 21; Vol. 30 (7), pp. 5953-5972. Date of Electronic Publication: 2023 Jun 21.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Sarcoma, Ewing*/diagnostic imaging
    Sarcoma, Ewing*/therapy
    Sarcoma*/diagnosis
    Sarcoma*/therapy
    Sarcoma*/pathology
    Retroperitoneal Neoplasms*/diagnosis
    Retroperitoneal Neoplasms*/therapy
    Retroperitoneal Neoplasms*/pathology
    Soft Tissue Neoplasms*
    Kidney Neoplasms*
    Adult ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study.
    Autorzy:
    Jobson D; Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
    Roffey B; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
    Arnold C; Hodgson Associates, Melbourne, Victoria, Australia.; Biogrid Australia, Parkville, Victoria, Australia.
    Azzi A; Newcastle Skin Check, Newcastle, New South Wales, Australia.; School of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Skin Cancer Institute, Singapore City, Singapore.; Skin Cancer College Australasia, Auchenflower, Queensland, Australia.; Australian College of Rural and Remote Medicine, Brisbane, Queensland, Australia.
    Button-Sloan A; Australian Melanoma Consumer Alliance, Melbourne, Victoria, Australia.
    Dawson T; Melanoma and Skin Cancer Advocacy Network, Carlton, Victoria, Australia.
    Fernandez-Penas P; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.; Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia.
    Fishburn P; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Norwest Skin Cancer Centre, New South Wales, Australia.
    Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
    Hiscutt EL; Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
    Jakrot V; Melanoma Institute Australia, Sydney, New South Wales, Australia.; The University of Sydney, New South Wales, Australia.
    Lilleyman A; Skin Cancer College Australasia, Auchenflower, Queensland, Australia.; Australian College of Rural and Remote Medicine, Brisbane, Queensland, Australia.
    Lochhead A; Southern IML Pathology, Wollongong, New South Wales, Australia.; Department of Anatomical Pathology, Wollongong Hospital, Wollongong, New South Wales, Australia.; Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
    Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Mater Hospital, Sydney, New South Wales, Australia.
    Mailer S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Melanoma Research Victoria, Melbourne, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Mann G; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; The John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.
    McCormack CJ; Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Muir J; University of Queensland, Brisbane, Queensland, Australia.; Mater Hospital, Brisbane, Queensland, Australia.
    Pratt GF; Plastic and Reconstructive Unit, Monash Health, Dandenong, Victoria, Australia.; Plastic and Reconstructive Surgery, Peninsula Health, Frankston, Victoria, Australia.
    Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
    Shackelton M; Central Clinical School and School of Public Health and Preventive Medicine, Monash University, Prahran, Victoria, Australia.; Department of Oncology, Alfred Health, Prahran, Victoria, Australia.
    Shumack S; Royal North Shore Hospital, Sydney, New South Wales, Australia.
    Soyer HP; The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.; Dermatology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
    Tan CG; Melbourne Pathology, Victoria, Australia.
    Webb A; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Skin Health Institute, Carlton, Victoria, Australia.
    Zalcberg J; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Department of Medical Oncology, Alfred Health, Prahran, Victoria, Australia.
    Morton R; Melanoma Institute Australia, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
    Mar V; Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
    Pokaż więcej
    Źródło:
    The Australasian journal of dermatology [Australas J Dermatol] 2022 Aug; Vol. 63 (3), pp. 344-351. Date of Electronic Publication: 2022 Apr 29.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Melanoma*/pathology
    Skin Neoplasms*/pathology
    Australia ; Delphi Technique ; Humans ; Quality Indicators, Health Care ; Registries
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Optimising the quality of multidisciplinary team meetings: A narrative review.
    Autorzy:
    Tran TH; University of Melbourne, Melbourne, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
    de Boer J; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
    Gyorki DE; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Krishnasamy M; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2022 May; Vol. 11 (9), pp. 1965-1971. Date of Electronic Publication: 2022 Mar 07.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Neoplasms*/therapy
    Patient Care Team*
    Clinical Decision-Making ; Data Collection ; Humans ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
    Autorzy:
    Bucknell NW; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
    Gyorki DE; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Bressel M; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Estall V; Department of Radiation Oncology, Liverpool Hospital, Sydney, New South Wales, Australia.; ICON Cancer Centre Epworth Hospital, I Epworth Place Warun Ponds Geelong, Waurn Ponds, Victoria, Australia.; South Western Sydney Clinical School UNSW Goulburn St, Liverpool, New South Wales, Australia.
    Webb A; Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Henderson M; Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Chua MS; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Rischin D; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Tiong A; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Pokaż więcej
    Źródło:
    The Australasian journal of dermatology [Australas J Dermatol] 2022 Feb; Vol. 63 (1), pp. 43-52. Date of Electronic Publication: 2021 Nov 09.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Lymphatic Metastasis*
    Carcinoma, Squamous Cell/*secondary
    Skin Neoplasms/*pathology
    Adult ; Age Factors ; Aged ; Aged, 80 and over ; Axilla/pathology ; Axilla/surgery ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/therapy ; Female ; Groin/pathology ; Groin/surgery ; Humans ; Immunocompromised Host ; Lymph Node Excision ; Male ; Middle Aged ; Progression-Free Survival ; Radiotherapy, Adjuvant ; Retrospective Studies ; Skin Neoplasms/mortality ; Skin Neoplasms/therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Accumulation of CD103 T cells in a cutaneous melanoma micrometastasis.
    Autorzy:
    Hochheiser K; Peter MacCallum Cancer Centre Melbourne VIC Australia.; Department of Microbiology & Immunology The University of Melbourne at the Peter Doherty Institute for Infection & Immunity Melbourne VIC Australia.
    Aw Yeang HX; Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia.
    Wagner T; Department of Microbiology & Immunology The University of Melbourne at the Peter Doherty Institute for Infection & Immunity Melbourne VIC Australia.; Telethon Kids Institute University of Western Australia Perth WA Australia.
    Tutuka C; Olivia Newton-John Cancer Research Institute Heidelberg VIC Australia.
    Behren A; Olivia Newton-John Cancer Research Institute Heidelberg VIC Australia.
    Waithman J; Telethon Kids Institute University of Western Australia Perth WA Australia.
    Angel C; Peter MacCallum Cancer Centre Melbourne VIC Australia.
    Neeson PJ; Peter MacCallum Cancer Centre Melbourne VIC Australia.; Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia.
    Gebhardt T; Department of Microbiology & Immunology The University of Melbourne at the Peter Doherty Institute for Infection & Immunity Melbourne VIC Australia.
    Gyorki DE; Peter MacCallum Cancer Centre Melbourne VIC Australia.; Department of Surgery University of Melbourne Melbourne VIC Australia.
    Pokaż więcej
    Źródło:
    Clinical & translational immunology [Clin Transl Immunology] 2019 Dec 25; Vol. 8 (12), pp. e1100. Date of Electronic Publication: 2019 Dec 25 (Print Publication: 2019).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Ectopic breast cancer in the inguinal region.
    Autorzy:
    Loh Z; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
    Yeo B; Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia.
    Williams DS; Department of Pathology, Austin Health, Heidelberg, Victoria, Australia.
    Gyorki DE; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
    Pokaż więcej
    Źródło:
    The breast journal [Breast J] 2019 Jan; Vol. 25 (1), pp. 155-156. Date of Electronic Publication: 2018 Dec 27.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Breast Neoplasms/*pathology
    Inguinal Canal/*pathology
    Breast Neoplasms/drug therapy ; Breast Neoplasms/surgery ; Female ; Humans ; Inguinal Canal/diagnostic imaging ; Magnetic Resonance Imaging ; Middle Aged ; Positron Emission Tomography Computed Tomography
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.
    Autorzy:
    Halse H; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Colebatch AJ; Division of Cancer Medicine Melanoma Program, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Petrone P; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Henderson MA; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Mills JK; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Snow H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Westwood JA; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Sandhu S; Division of Cancer Medicine Melanoma Program, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3052, Australia.
    Raleigh JM; Division of Cancer Medicine Melanoma Program, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Behren A; Olivia Newton John Cancer Research Institute, Heidelberg, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, 3086, Australia.
    Cebon J; Olivia Newton John Cancer Research Institute, Heidelberg, Victoria, 3084, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, 3086, Australia.
    Darcy PK; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3052, Australia.
    Kershaw MH; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3052, Australia.
    McArthur GA; Division of Cancer Medicine Melanoma Program, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.
    Gyorki DE; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia.; Department of Surgery, University of Melbourne, Parkville, Victoria, 3052, Australia.
    Neeson PJ; Cancer Immunology Research, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, 3000, Australia. .; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3052, Australia. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2018 Jul 24; Vol. 8 (1), pp. 11158. Date of Electronic Publication: 2018 Jul 24.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Immunohistochemistry/*methods
    Melanoma/*immunology
    Melanoma/*pathology
    Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/immunology ; Antineoplastic Agents, Immunological/therapeutic use ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes/immunology ; Flow Cytometry ; Humans ; Ipilimumab/immunology ; Ipilimumab/therapeutic use ; Lymphocyte Activation ; Lymphocytes, Tumor-Infiltrating ; Macrophages/metabolism ; Melanoma/drug therapy ; Metastasectomy ; Middle Aged ; Prospective Studies ; Statistics, Nonparametric ; T-Lymphocytes, Regulatory/immunology ; Tumor Escape
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'.
    Autorzy:
    Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
    Barbour A; Upper Gastrointestinal and Soft Tissue Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Surgical Oncology Laboratory, Discipline of Surgery, University of Queensland, Brisbane, Queensland, Australia.
    Hanikeri M; Western Australia Melanoma Advisory Service, Perth, Western Australia, Australia.
    Mar V; Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Skin and Cancer Foundation Inc., Melbourne, Victoria, Australia.
    Sandhu S; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
    Thompson JF; Melanoma Institute Australia, Poche Centre, Sydney, New South Wales, Australia.; Discipline of Surgery, University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
    Pokaż więcej
    Źródło:
    The Australasian journal of dermatology [Australas J Dermatol] 2017 Nov; Vol. 58 (4), pp. 274-277. Date of Electronic Publication: 2017 Jul 17.
    Typ publikacji:
    Journal Article; Review; Systematic Review
    MeSH Terms:
    Patient Selection*
    Sentinel Lymph Node Biopsy*/adverse effects
    Melanoma/*secondary
    Sentinel Lymph Node/*pathology
    Skin Neoplasms/*pathology
    Humans ; Lymphatic Metastasis ; Melanoma/therapy ; Neoplasm Staging ; Practice Guidelines as Topic ; Skin Neoplasms/therapy ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
    Autorzy:
    Lim E; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
    Vaillant F
    Wu D
    Forrest NC
    Pal B
    Hart AH
    Asselin-Labat ML
    Gyorki DE
    Ward T
    Partanen A
    Feleppa F
    Huschtscha LI
    Thorne HJ
    Fox SB
    Yan M
    French JD
    Brown MA
    Smyth GK
    Visvader JE
    Lindeman GJ
    Pokaż więcej
    Corporate Authors:
    kConFab
    Źródło:
    Nature medicine [Nat Med] 2009 Aug; Vol. 15 (8), pp. 907-13. Date of Electronic Publication: 2009 Aug 02.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Genes, BRCA1*
    Heterozygote*
    Breast Neoplasms/*genetics
    Cell Transformation, Neoplastic/*genetics
    Stem Cells/*pathology
    Breast Neoplasms/etiology ; Cells, Cultured ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Mammary Glands, Human/cytology ; Mammary Glands, Human/metabolism ; Mammary Glands, Human/pathology ; Models, Biological ; Mutation/physiology ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Precancerous Conditions/genetics ; Precancerous Conditions/metabolism ; Precancerous Conditions/pathology ; Receptors, Progesterone/metabolism ; Stem Cells/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-14 z 14

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies